G0F 2AB (500pmol/vial)1vial

1-{3-[(2-Chloro-6-fluorobenzyl)oxy]phenyl}-1-ethanone, 250mg

Cyclopropyl isothiocyanate, 97.0%, 1g

2,2'-Oxybis(ethylamine) Dihydrochloride>98.0%(N)(T)1g

2-Thiouridine>98.0%(HPLC)(qNMR)100mg

(6,7-Dimethyl-5-oxo-2,3-dihydro-5H-[1,3]thiazolo[3,2-a]pyrimidin-3-yl)acetic acid, 95.0%, 250mg

Methyl 2-amino-4-chlorobenzo[d]thiazole-6-carboxylate, 97.0%, 250mg

1-(1-Methylethyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 250mg

Diethyl 2,2-difluoropentanedioate, 95.0%, 25g

5-Bromo-3-methoxypyrazin-2(1H)-one, 98.0%, 1g

5-Formyl-2-(4-methyl-1H-imidazol-1-yl)-Benzonitrile, 95%, 1g

(R)-4-Hydroxy-N,N-diphenylpent-2-ynamide, 95.0%, 5g

(S)-Dibenzyl 2-aminopentanedioate hydrochloride, 95.0%, 25g